Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

271.36
+4.671.75%
Pre-market: 271.430.0700+0.03%06:25 EDT
Volume:6.08M
Turnover:1.65B
Market Cap:479.60B
PE:76.66
High:274.94
Open:268.40
Low:266.89
Close:266.69
52wk High:274.94
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.16
T/O Rate:0.34%
Dividend:6.83
Dividend Rate:2.52%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-80.81
PE(LYR):114.98

Loading ...

US FDA Approves AbbVie's Drug for Parkinson's Disease

Reuters
·
Sep 26

US FDA - Approves Juvmo (Tavapadon) for Parkinson’s Disease in Adults on Sept 25, 2026

THOMSON REUTERS
·
Sep 26

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

Reuters
·
Sep 26

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults

Reuters
·
Sep 24

Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma

THOMSON REUTERS
·
Sep 24

RBC Capital Sticks to Its Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Sep 24

Oruka Falls After Reporting Mid-Stage Data for Psoriasis Drug

Reuters
·
Sep 23

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

Reuters
·
Sep 23

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22

AbbVie Doubles Down: SiRNA Player Adarx Targets $372M Nasdaq IPO At $1.74B Valuation

Bellwether Stocks Movement
·
Sep 22

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

Reuters
·
Sep 22

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Reuters
·
Sep 22

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS
·
Sep 22

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS
·
Sep 22

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 22

Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On

Reuters
·
Sep 22

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

AbbVie, Iambic Sign Multiyear Drug Discovery Deal

MT Newswires Live
·
Sep 21